A recent study from the Mass General Cancer Center finds that statins may block a pathway involved in cancer development due to chronic inflammation, showing promise in preventing cancers associated with environmental toxins, particularly in skin and pancreas.
Research results show that pitavastatin suppresses skin and pancreatic cancers by inhibiting interleukin-33.
A recent study by researchers at the Mass General Cancer Center found that statins, widely used to lower cholesterol, may inhibit a specific pathway linked to the development of cancer caused by chronic inflammation. These results were reported in
